Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progress in standards for reporting omics data.

Chris F Taylor1

  • 1European Bioinformatics Institute, Hinxton, Cambridgeshire CB10 1SD, UK. chris.taylor@ebi.ac.uk

Current Opinion in Drug Discovery & Development
|June 9, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Ontology for Biomedical Investigations.

PloS one·2016
Same author

Recombinant protein quality evaluation: proposal for a minimal information standard.

Standards in genomic sciences·2011
Same author

Data standards for Omics data: the basis of data sharing and reuse.

Methods in molecular biology (Clifton, N.J.)·2011
Same author

Towards interoperable reporting standards for omics data: hopes and hurdles.

Summit on translational bioinformatics·2011
Same author

Guidelines for reporting the use of capillary electrophoresis in proteomics.

Nature biotechnology·2010
Same author

Guidelines for reporting the use of gel image informatics in proteomics.

Nature biotechnology·2010
Same journal

Microreactors for continuous processing – How close to commercial utility?

Current opinion in drug discovery & development·2010
Same journal

Synthesis of polyketide natural products and analogs as promising anticancer agents.

Current opinion in drug discovery & development·2010
Same journal

Enantioselective synthesis of substituted oxindoles and spirooxindoles with applications in drug discovery.

Current opinion in drug discovery & development·2010
Same journal

Eliminating pharmaceutical impurities: Recent advances in detection techniques.

Current opinion in drug discovery & development·2010
Same journal

Stereoselective heterocycle synthesis through oxidative carbon-hydrogen bond activation.

Current opinion in drug discovery & development·2010
Same journal

Catalysis in aqueous media for the synthesis of drug-like molecules.

Current opinion in drug discovery & development·2010
See all related articles

Standardized reporting for biological and biomedical experiments is emerging to ensure data longevity and integration. These standards, developed with industry and academia, are crucial for drug discovery and development.

Area of Science:

  • Biomedical research
  • Data science

Background:

  • Growing need for robust data management in biological and biomedical experiments.
  • Concerns regarding data set longevity and the reproducibility of scientific conclusions.
  • Desire to integrate data across diverse scientific disciplines for comprehensive analysis.

Purpose of the Study:

  • To review the context and nature of emerging standards for experimental reporting.
  • To discuss the relevance of these new standards to pharmaceutical drug discovery and development.

Main Methods:

  • Review of current initiatives and candidate standards for experimental data reporting.
  • Analysis of the roles played by research groups, the pharmaceutical industry, technology vendors, and academia.

Main Results:

Related Experiment Videos

  • Development of standardized mechanisms and protocols for reporting biological and biomedical experiments.
  • Significant involvement of the pharmaceutical industry, technology vendors, and academia in standard creation.
  • Identification of key drivers including data longevity, data integration, and data mining.

Conclusions:

  • Emerging standards are critical for enhancing the reliability and usability of experimental data.
  • These standards are particularly relevant for advancing drug discovery and development processes.
  • Collaboration between diverse stakeholders is key to successful standard implementation.